These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19692102)

  • 1. A comparison of the effects of hydromorphone HCl and a novel extended release hydromorphone on arterial blood gas values in conscious healthy dogs.
    Wunsch LA; Schmidt BK; Krugner-Higby LA; Smith LJ
    Res Vet Sci; 2010 Feb; 88(1):154-8. PubMed ID: 19692102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hypoxemia and hypercarbia in healthy dogs undergoing routine ovariohysterectomy or castration and receiving butorphanol or hydromorphone for analgesia.
    Campbell VL; Drobatz KJ; Perkowski SZ
    J Am Vet Med Assoc; 2003 Feb; 222(3):330-6. PubMed ID: 12564595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs.
    Kuo WC; Keegan RD
    Am J Vet Res; 2004 Jul; 65(7):931-7. PubMed ID: 15281651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single dose of liposome-encapsulated hydromorphone provides extended analgesia in a rat model of neuropathic pain.
    Smith LJ; Valenzuela JR; Krugner-Higby LA; Brown C; Heath TD
    Comp Med; 2006 Dec; 56(6):487-92. PubMed ID: 17219779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs.
    Smith LJ; KuKanich B; Hogan BK; Brown C; Heath TD; Krugner-Higby LA
    J Vet Pharmacol Ther; 2008 Oct; 31(5):415-22. PubMed ID: 19000260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hydromorphone extended-release.
    Guay DR
    Consult Pharm; 2010 Dec; 25(12):816-28. PubMed ID: 21172762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydromorphone or oxymorphone, with or without acepromazine, on preanesthetic sedation, physiologic values, and histamine release in dogs.
    Smith LJ; Yu JK; Bjorling DE; Waller K
    J Am Vet Med Assoc; 2001 Apr; 218(7):1101-5. PubMed ID: 11318359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
    Yang Y; Wu J; Li H; Ye S; Xu X; Cheng L; Zhu L; Peng Z; Feng Z
    BMC Anesthesiol; 2018 Apr; 18(1):37. PubMed ID: 29636011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of orally administered sustained- release hydromorphone in humans.
    Angst MS; Drover DR; Lötsch J; Ramaswamy B; Naidu S; Wada DR; Stanski DR
    Anesthesiology; 2001 Jan; 94(1):63-73. PubMed ID: 11135723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxymorphone hydrochloride or hydromorphone hydrochloride on minimal alveolar concentration of desflurane in sheep.
    Sayre RS; Lepiz MA; Horsley KT; Pashmakova MB; Barr JW; Washburn SE
    Am J Vet Res; 2015 Jul; 76(7):583-90. PubMed ID: 26111087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs.
    Hofmeister EH; Chandler MJ; Read MR
    J Am Vet Med Assoc; 2010 Nov; 237(10):1155-9. PubMed ID: 21073386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of acupuncture point Pericardium 6 on hydromorphone-induced nausea and vomiting in healthy dogs.
    Scallan EM; Simon BT
    Vet Anaesth Analg; 2016 Sep; 43(5):495-501. PubMed ID: 26890432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M; Tudor IC; Khanna S; Thipphawong J
    Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydromorphone-OROS formulation.
    Goforth HW
    Expert Opin Pharmacother; 2010 May; 11(7):1207-14. PubMed ID: 20402557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metamorphosis of hydromorphone.
    Reisfield GM; Wilson GR
    J Opioid Manag; 2005; 1(3):139-45. PubMed ID: 17315417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ammonium sulfate gradient loaded liposome-encapsulated oxymorphone and hydromorphone in healthy dogs.
    Smith LJ; Kukanich BK; Krugner-Higby LA; Schmidt BH; Heath TD
    Vet Anaesth Analg; 2013 Sep; 40(5):537-45. PubMed ID: 23601353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.